Sector: Technology | Industry: Semiconductors |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 5 David Fikes Street REHOVOT 7610201 |
Tel: | N/A |
Website: | https://www.novami.com |
IR: | See website |
Key People | ||
Eitan Oppenhaim Executive Chairman of the Board | Gabriel Waisman President, Chief Executive Officer | Dror David Chief Financial Officer |
Adrian S. Wilson President of US subsidiary and General Manager Material Metrology Division | Gabi Sharon Chief Operating Officer | Sharon Dayan Chief Human Resource Officer |
Shay Wolfling Chief Technology Officer | Zohar Gil Chief Marketing Officer | Effi Aboody Corporate Vice President and General Manager Dimensional Metrology Division |
Business Overview |
Nova Ltd, former Nova Measuring Instruments Ltd,is an Israel based company which provides metrology solutions for the semiconductor manufacturing industry. The Company offers in-line Optical and x-ray stand-alone metrology systems, as well as integrated optical metrology systems, which are attached directly to wafer fabrication process equipment. Its metrology systems measure various film thickness and composition properties, as well as critical-dimension (CD) variables during various front-end and back-end of line steps in the semiconductor wafer fabrication process. Its product portfolio includes a set of in-situ, integrated and stand-alone metrology platforms suited for dimensional, films and material metrology measurements for process control across multiple semiconductor manufacturing process steps. Its products include NovaScan 2040, NovaScan 3090Next, Nova i500, Nova T500, Nova T600, Nova V2600 TSV metrology system among others. |
Financial Overview |
For the fiscal year ended 31 December 2023, Nova Ltd (USA) revenues decreased 9% to $517.9M. Net income decreased 3% to $136.3M. Revenues reflect Taiwan R.O.C. segment decrease of 49% to $93.2M, United States segment decrease of 26% to $67.3M. Net income also reflects Exchange rate income (loss), net decrease of 62% to $1.3M (income), Stock-based Compensation in R&D increase of 13% to $7.7M (expense). |